Cardiolipin Antibody IgM, Serum
Profile image
Cardiolipin Antibody IgM, Serum
icon

Expert Service Provider

icon

24/7 Customer Support

Starting at ₹550

$599
50% OFF

Know more about this test

Age Group

All Ages

Sample Required

Blood
icon

Test For

Men,Women

Contains

1 Tests

Tests

available at

Lab

Preparations

No Special Preparation.

Tests Included

This test focuses on the core laboratory parameters for Anti-Cardiolipin Antibodies (IgM).
Supports diagnosis and monitoring, providing clinically relevant insights related to anti-cardiolipin antibodies (IgM) for accurate assessment and decision making.

Card feature imageCard feature image mobile

Test from the comfort of your home

Expert Legal Advice

Book. Relax. We collect from home. SmartLabs makes testing effortless schedule online or call us.

24/7 Consultation
Available round the clock for your urgent needs.
Follow Us
iconiconicon

Know More About This Test

Anti-Cardiolipin Antibodies (IgM) are autoantibodies associated with Antiphospholipid Syndrome (APS), a condition that increases the risk of abnormal blood clots and recurrent pregnancy loss.

This test helps identify autoimmune-related clotting disorders by detecting these specific antibodies in the blood. Persistent positivity on repeat testing indicates APS, while transient positivity may occur during infections.

Why Is This Test Recommended?

Anti-Cardiolipin Antibodies (IgM) testing is recommended to evaluate unexplained thrombosis, investigate recurrent miscarriages, and diagnose autoimmune clotting disorders. It is used to assess stroke or deep vein thrombosis (DVT) in young patients without traditional risk factors.

The test helps identify individuals at risk for thrombotic complications and pregnancy-related complications associated with Antiphospholipid Syndrome.

Symptoms or Conditions That May Require This Test

You may need this test if you experience:

  • One or more unexplained blood clots in arteries or veins including leg swelling, leg pain, sudden breathlessness, or chest pain.

  • Recurrent miscarriages particularly one or more unexplained losses of a normal foetus beyond the 10th gestational week, three or more spontaneous abortions before the 10th week, or one or more premature births before the 34th week due to eclampsia or placental insufficiency

  • Symptoms of SLE or other systemic autoimmune conditions including a butterfly-shaped facial rash, joint pain, unexplained fever, photosensitivity, or renal involvement where antiphospholipid antibody co-existence needs to be assessed

  • Livedo reticularis a mottled, net-like purplish skin discoloration on the arms or legs which is a recognized non-criterial clinical feature associated with antiphospholipid antibodies

  • Unexplained thrombocytopenia (low platelet count), cardiac valvular disease, or neurological symptoms including migraines, seizures, or transient ischaemic attacks, where an autoimmune thrombotic mechanism requires investigation

  • Bleeding from the nose or gums, heavy menstrual periods, or unexplained bruising paradoxically, some patients with APS experience bleeding complications despite the prothrombotic nature of the condition, due to associated thrombocytopenia

Advantages of Cardiolipin IgM Screening

  • Early Detection: It can identify a clotting risk before a major event like a stroke occurs.

  • Specific Diagnosis: Helps distinguish between "Primary APS" (standalone) and "Secondary APS" (linked to Lupus).

  • Informed Pregnancy Planning: Allows for specialized care and medications to help maintain a healthy pregnancy in women with a history of loss.

How Is the Test Performed and Prepared For?

A blood sample is collected through standard venipuncture for laboratory analysis. No fasting is required for this test. Avoid testing during acute infection as it may cause transient false-positive results.

If initial results are positive, repeat testing after 12 weeks is essential to confirm persistent positivity before diagnosing Antiphospholipid Syndrome.

What Do the Results Mean?

Results are measured in MPL units. While ranges vary slightly by lab, general interpretations are:

Result Level,Value (MPL U/mL),Interpretation

Negative,< 15.0,Normal; no significant IgM antibodies detected.

Weak Positive,15.0 – 40.0,Possible temporary elevation due to recent infection.

Positive,> 40.0,High risk for APS or associated autoimmune conditions.

Lifestyle Tips to Manage Antiphospholipid Antibodies

While you cannot "flush out" antibodies through diet alone, you can significantly reduce the risk of the blood clots they cause. If your Cardiolipin IgM levels are elevated, focus on these heart-healthy and circulation-friendly habits:

  • Stay Active: Regular walking (30 minutes daily) keeps blood flowing and prevents clots from forming in the legs.

  • Hydrate Well: Dehydration makes blood "thicker." Aim for 2–3 liters of water daily.

  • Quit Smoking: Smoking damages blood vessel walls and drastically increases the risk of stroke and DVT when combined with these antibodies.

  • Move on Long Flights/Drives: If traveling for more than 4 hours, wear compression stockings and perform ankle pumps every hour.

  • Manage Estrogen Intake: Discuss birth control or Hormone Replacement Therapy (HRT) with your doctor, as estrogen can further increase clotting risks.

  • Healthy Weight: Maintaining a healthy BMI reduces the pressure on your veins and lowers overall inflammation.

Frequently Asked Questions (FAQs)

  • Is one positive test enough?
    No, repeat needed; APS diagnosis requires positive results on at least two occasions, 12 weeks or more apart, to confirm persistent antibody presence.

  • Is APS treatable?
    Yes, with anticoagulation; treatment typically involves anticoagulant medications like aspirin or warfarin to prevent clotting, with specific protocols during pregnancy.

  • Can infections cause false positives?
    Yes; acute viral or bacterial infections can temporarily elevate antibody levels, which is why confirmation testing after recovery is important.

  • Is this test used in pregnancy?
    Yes; it is commonly ordered in cases of recurrent miscarriage, unexplained pregnancy loss, or complications like preeclampsia or placental insufficiency.

  • Is lifelong treatment required?
    Sometimes; patients with confirmed APS and history of thrombosis typically require long-term anticoagulation, while others may need treatment only during high-risk periods.